ACCELERATING THE WORLD’S TRANSITION TO MEDICAL VR TRAINING.

ORamaVR was created to tackle a major health crisis that is currently affecting almost 5B people globally: the lack of access to affordable surgical care. This health crisis is the direct result of a lack of innovation in medical training over the last 150 years that has meant that the profession can’t keep up with the demand. The WHO is projecting that by 2030, there will be a staggering deficit of 18 million medical professionals. Meanwhile, the number of fatal medical errors keeps rising due to the fact that medical training is highly intensive: a master/ educator operates on a patient and the trainee/ apprentice observes and learns on-the-job, often practicing on real patients.

Medical virtual reality (VR) training can change all that. Clinical studies have proven that medical VR training improves patient outcomes; however, current VR content creation cannot keep up with the demand, due to: a) lengthy content creation times b) high authoring costs and c) a very large number of different medical operations that need to be simulated in VR.

ORamaVR aims to accelerate the world’s transition to medical VR training by offering an IT software platform called MAGES™ SDK(Software Development Kit). This platform empowers institutions and developers to massively create high fidelity medical Virtual Reality Simulations 8 times faster and for one eighth of the cost relative to current industry standards. These state-of-the-art simulations can thus quickly and more affordably be made available to hospitals, medical device companies, medical schools and medical training centres to train and assess their medical professionals. The outstanding benefits of this award-winning platform (MAGES SDK) have been demonstrated in 4 published clinical trials. Aside from drastically reducing development costs and delays, the platform has been proven to provide effective skills transfer from the virtual to the real operating table.

ORamaVR was founded in 2016 as a spin-off startup of the Foundation of Technology- Hellas, Institute of Computer Science (FORTH-ICS) and received initial pre-seed financing from the VC PJ TECH CATALYST FUND in Greece. Following a strategic partners’ demand, the company moved its HQ to Geneva, Switzerland in 2020. Numerous high profile institutions have already adopted and endorsed ORamaVR, including (but not limited to) the USC Keck School of Medicine, Los Angeles, NYU Langone Medical School in New York, the University of Geneva, the Swiss Foundation for Innovation and Training in Surgery(SFITS), Virtamed™  SA and the Inselspital Hospital system in Switzerland, the University of Athens, Greece and recently Western Governors University, Fayetteville State University, Atrium Health and the University of Michigan in USA as well as the University of Cologne, and nonNocere SA in Germany.

ORamaVR has been awarded the “best societal impact” award by the Latsis Foundation (2021), the Epic Games Mega-Grant (2020), the Augmented World Expo (AWE) Auggie award for “Best Societal Impact” (2019) and the prestigious FARE award by the American Association of Hip and Knee Surgeons (AAHKS) (2018). ORamaVR has attracted substantial deep-tech R&D grants from the European Commission and boasts important research and industrial partnerships, including Airbus, Telefonica, CNRS and Eurescom. In 2020, ORamaVR successfully concluded a financing round led by HTC Vive, a leader in enterprise virtual reality.